Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.750
-0.050 (-1.32%)
At close: Apr 7, 2026, 4:00 PM EDT
3.990
+0.240 (6.40%)
Pre-market: Apr 8, 2026, 4:04 AM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $521.23 million as of April 7, 2026. Its market cap has increased by 201.87% in one year.
Market Cap
521.23M
Enterprise Value
371.98M
1-Year Change
201.87%
Ranking
Category
Stock Price
$3.75
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $521.23M, an increase of 143.05%. That is a compound annual growth rate of 8.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 521.23M | 59.83% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 581.32M |
| Zura Bio | 579.72M |
| Zevra Therapeutics | 579.48M |
| MiMedx Group | 576.44M |
| ProKidney | 570.62M |
| CorMedix | 559.28M |
| Kyverna Therapeutics | 557.40M |
| Fulcrum Therapeutics | 548.12M |